A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales
- 9 September 2014
- journal article
- Published by Springer Nature in Quality of Life Research
- Vol. 24 (3) , 631-639
Abstract
People with severe asthma experience significant respiratory symptoms and suffer adverse effects of oral corticosteroids (OCS), including disturbed mood and physical symptoms. OCS impacts on health-related quality of life (HRQoL) have not been quantified. Asthma HRQoL scales are valid as outcome measures for patients requiring OCS only if they assess the deficits imposed by OCS. The aim of this study was to compare the burden of disease and treatment in patients with severe asthma with items in eight asthma-specific HRQoL scales. Twenty-three patients with severe asthma recruited from a severe asthma clinic were interviewed about the impact of their respiratory symptoms and the burden of their treatment. The domains from a thematic analysis of these interviews were compared with the items of eight asthma-specific HRQoL scales. In addition to the burden caused by symptoms, ten domains of OCS impact on HRQoL were identified: depression, irritability, sleep, hunger, weight, skin, gastric, pain, disease anxiety, and medication anxiety. Some patients experienced substantial HRQoL deficits attributed to OCS. Although all HRQoL scales include some OCS-relevant items, all eight scales fail to adequately assess the several types of burden experienced by some patients while on OCS. The burden of OCS in severe asthma is neglected in policy and practice because it is not assessed in outcome studies. Existing asthma HRQoL scales provide an overly positive estimation of HRQoL in patients with frequent exposure to OCS and underestimate the benefit of interventions that reduce OCS exposure. Changes to existing measurement procedures are needed.Keywords
This publication has 28 references indexed in Scilit:
- What do we know about the safety of corticosteroids in rheumatoid arthritis?Current Medical Research and Opinion, 2013
- Cognitive behavioural intervention for adults with anxiety complications of asthma: Prospective randomised trialRespiratory Medicine, 2012
- Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinionBritish Journal of Dermatology, 2007
- Difficult asthma: people's perspectives on taking corticosteroid therapyJournal of Clinical Nursing, 2007
- Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndromeClinical Rheumatology, 2006
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Treatment of Allergic Asthma with Monoclonal Anti-IgE AntibodyNew England Journal of Medicine, 1999
- Measurement of psychological distress in asthma and asthma management programmesBritish Journal of Clinical Psychology, 1995
- Selection of Items and Avoidance of Bias in Quality of Life ScalesPharmacoEconomics, 1992
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992